logo
Select company
Select metric
-76.78%EBIT Margin
VS
Market
14
Sector
41
Industry
14
History
30
$ 0.53Close
$ 0.43 - $ 1.33 52-Week Range
Ticker Information

Ticker

MLSS

Company Name

MILESTONE SCIENTIFIC INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NYSEMKT

MILESTONE SCIENTIFIC INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MLSS - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -6.97M-76.78%$ 9.08M
3/31/2025$ -5.29M-61.4%$ 8.61M
12/31/2024$ -4.71M-54.62%$ 8.63M
9/30/2024$ -4.76M-53.62%$ 8.88M
6/30/2024$ -4.77M-56.58%$ 8.42M
3/31/2024$ -7.23M-76.31%$ 9.48M
12/31/2023$ -7.05M-71.79%$ 9.83M
9/30/2023$ -7.06M-72.03%$ 9.81M
6/30/2023$ -7.6M-76.25%$ 9.96M
3/31/2023$ -8.19M-94.16%$ 8.7M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MILESTONE SCIENTIFIC INC's latest trailing twelve months (TTM) EBIT % stands at -164.6%.
  • Over the past 5 years, MILESTONE SCIENTIFIC INC's average EBIT % has been -82.33%.
  • The median EBIT % for MILESTONE SCIENTIFIC INC during this period was -76.28%
  • MILESTONE SCIENTIFIC INC reached its highest EBIT % over the past 5 years at -53.62%.
  • The lowest EBIT % recorded by MILESTONE SCIENTIFIC INC in the same timeframe -164.6%

MILESTONE SCIENTIFIC INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
NMTC : NEUROONE MEDICAL TECHNOLOGIES CORP -55.42%NXGL : NEXGEL INC -24.37%VERU : VERU INC -482.04%CUE : CUE BIOPHARMA INC -463.15%FEMY : FEMASYS INC -1017.66%NEPH : NEPHROS INC 8.1%PSTV : PLUS THERAPEUTICS INC -287.76%OVID : OVID THERAPEUTICS INC -574.02%BCAB : BIOATLA INC -541.05%ALGS : ALIGOS THERAPEUTICS INC -1936.36%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for MILESTONE SCIENTIFIC INC is calculated as follows: EBIT [ $ -9.1M ] / Revenues [ $ 5.53M ]
(=) EBIT % [ -164.6% ]

MLSS - EBIT Margin, Last 5 years

-164.6%

Minimum

Sep 30, 2020

-53.62%

Maximum

Sep 30, 2024

-82.33%

Average

-76.28%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.56% with a standard deviation of 23.95%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.56%
median9.02%
std23.95%